Appian Corporation (NASDAQ: APPN - Get Free Report) has been assigned a consensus recommendation of

Appian is experiencing accelerating growth, driven by its differentiated AI-powered business process

DA Davidson analyst Lucky Schreiner maintains Appian (NASDAQ:APPN) with a Neutral and raises the

Joint architecture combines Synechron's InsureMESH with the Appian Platform to help carriers moderni

Appian (NASDAQ: APPN) reported second-quarter 2025 results that exceeded its guidance for cloud subs

Appian Corporation (NASDAQ: APPN - Get Free Report)'s stock price was up 14.2% on Friday after the c

DA Davidson analyst Lucky Schreiner maintains Appian (NASDAQ:APPN) with a Neutral and raises the

Citigroup analyst Steven Enders maintains Appian (NASDAQ:APPN) with a Buy and raises the price ta

Appian NASDAQ: APPN reported second-quarter 2026 results that exceeded its guidance, with cloud subs

Morgan Stanley analyst Sanjit Singh maintains Appian (NASDAQ:APPN) with a Equal-Weight and raises

While the top- and bottom-line numbers for Appian (APPN) give a sense of how the business performed

Appian beat estimates on the top and bottom lines, and raised its guidance. The stock pulled back in

Appian (APPN) stock dipped following its fiscal Q2 report, despite 19% revenue growth, beating Wall

Appian Corporation (APPN) Q2 2026 Earnings Call Transcript

Appian NASDAQ: APPN reported second-quarter 2025 results that exceeded its guidance for cloud subscr

Appian (NASDAQ:APPN) reported quarterly earnings of $0.13 per share which beat the analyst consensus

Appian (NASDAQ:APPN) raises FY2026 Adj EPS guidance from $0.94-$1.05 to $1.04-$1.12 vs $0.99 analyst

Appian (NASDAQ:APPN) is looking for Q3 Adj EPS of $0.31-$0.35 vs $0.32 analyst estimate. sees sales

Cloud subscriptions revenue increased 23% year-over-year to $131.7 million Cloud subscriptions reven

First Trust Advisors LP grew its holdings in Appian Corporation (NASDAQ: APPN) by 16.9% in the undef

Appian Corporation (NASDAQ: APPN - Get Free Report) gapped up prior to trading on Friday. The stock

MCLEAN, Va., July 16, 2026 (GLOBE NEWSWIRE) -- Appian (NASDAQ: APPN) today announced that it will re

CEO Matthew Calkins sold 50,000 shares on June 8, 2026, for a transaction value of approximately $1.

Appian Corporation APPN aims to improve the reliability of enterprise AI by embedding agentic capabi

Appian stands out as a business process re-engineering software company benefiting from long-standin

Matt Calkins, CEO of Appian weighs in on the SpaceX IPO, saying he wouldn't want to invest at this p

Survey finds agencies prioritizing governance, oversight, and operational efficiency as AI adoption

U.S. stock futures rise, Nasdaq up 1%. Graham Corp shares down 8.7%. Other stocks declining in pre-m

Software M&A activity has returned in 2026 as public SaaS multiples compress while private equity dr

DA Davidson analyst Lucky Schreiner maintains Appian (NASDAQ:APPN) with a Neutral and lowers the

TD Cowen analyst Derrick Wood maintains Appian (NASDAQ:APPN) with a Hold and lowers the price tar

Citigroup analyst Steven Enders maintains Appian (NASDAQ:APPN) with a Buy and lowers the price ta

Barclays analyst Raimo Lenschow maintains Appian (NASDAQ:APPN) with a Underweight and raises the

Appian (APPN) stock edges higher after a Q1 earnings double-beat and a massive full-year profit hike

Appian (NASDAQ:APPN) raises FY2026 Adj EPS guidance from $0.82-$0.96 to $0.94-$1.05 vs $0.89 analyst

Appian (NASDAQ:APPN) is looking for Q2 Adj EPS of $(0.02)-$0.02 vs $0.10 analyst estimate. sees sale

Appian (NASDAQ:APPN) reported quarterly earnings of $0.27 per share which beat the analyst consensus

Top analysts downgraded APPN and XOMA stocks. Visit analyst ratings page to see other views. Should

Top Wall Street analysts changed their outlook on top names. See all rating changes at https://www.b

Appian Corp (APPN) stock gained on strong Q2 results, beating revenue estimates and increasing subsc

Pegasystems exceeded expectations in Q2 2025, with robust revenue and cloud growth. Analysts maintai

All three major U.S. indices are red in Wednesday's midday trading as investors weighed Presiden

CMMB: 41% | Chemomab Therapeutics shares are trading higher after the company announced the completi